Phlexglobal, the specialist provider of innovative Trial Master File
(TMF) and electronic Trial Master File (eTMF) expertise, solutions and
services to the life sciences industry, announced today that it has been
acquired by Bridgepoint Development Capital ('BDC').
BDC, with a particular interest in life sciences, acquires companies
with strong market positions and earnings growth potential. Phlexglobal
are the world-wide acknowledged TMF Experts, providing TMF solutions,
from its best of breed eTMF system PhlexEview, to a range of support
services. Previously backed by Inflexion, BDC's greater reach with more
access to capital will further support Phlexglobal's plans to develop
technologies, expand its client base across Pharma, Biotech and Contract
Research Organizations and extend its global footprint.
Alan Payne, partner at BDC, said: "With the increasing emergence of
technology in the TMF market, the company is now well placed to
replicate its eminence in the services market to become the eTMF
provider of choice and the leading TMF services brand."
Stella Donoghue, Phlexglobal managing director said "We are very excited
about working with BDC. They will bring a renewed energy and are focused
on supporting our growth across the business. Our current management
team will remain unchanged, continuing with the business to drive that
Chairman Steve Kent is confident of Phlexglobal's position in the future
of TMF management "Our technology platform is recognized to be a market
leading solution and we intend to cement that position by introducing
new, and innovative efficient offerings to our customers."
About Bridgepoint Development Capital
BDC provides funding to businesses headquartered in France, the Nordic
region and the UK. BDC has a team of 19 investment professionals wholly
dedicated to its investment activity and operating from offices in
London, Paris and Stockholm. It is part of Bridgepoint, the
international private equity group, which invests in businesses valued
between €200 million and €1 billion across Europe.
More information can be found at www.bridgepoint.eu
Phlexglobal is a specialist provider of technology-enabled, Trial Master
File (TMF & eTMF) document management solutions and other support
services. They offer a unique combination of clinical trial knowledge,
document management skills, regulatory understanding and technical
expertise to deliver a range of flexible, targeted solutions to meet
More information can be found at http://www.phlexglobal.com
[ Back To NFVZone's Homepage ]